Interaction between baseline HBV loads and the prognosis of patients with HCC receiving anti-PD-1 in combination with antiangiogenic therapy undergoing concurrent TAF prophylaxis

Peer Review reports

Original Submission
21 Apr 2022	Submitted	Original manuscript
9 May 2022	Reviewed	Reviewer Report
14 Jun 2022	Reviewed	Reviewer Report
19 Jun 2022	Author responded	Author comments - Jinzhang Chen
Resubmission - Version 2
19 Jun 2022	Submitted	Manuscript version 2
6 Jul 2022	Reviewed	Reviewer Report
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
7 Jul 2022	Editorially accepted
14 Jul 2022	Article published	10.1186/s12879-022-07602-0

Back to article page